It was early 2020 when the head of Moderna’s vaccine development team first met with Eurofins Viracor. Moderna scientists were working feverishly to move their COVID-19 vaccine candidate programme into the clinical phase, but their laboratory partner did not have all the validated assays ready to meet the needs of the trial. Eurofins Viracor was also gearing up to enter the fight against the … [Read more...] about Eurofins Viracor BioPharma partners with Moderna, performing essential clinical trial testing for COVID-19 Vaccine
Blog
Eurofins Launches New ultra-fast Extraction-free RT-PCR Method and Upgrades its RT-PCR Assay for Use with Pharynx Gargle and Saliva Sample Matrices
Launch of the GSD NovaPrime® SARS-CoV-2 Direct RT-PCR The GSD NovaPrime® SARS-CoV-2 Direct RT-PCR is intended for the qualitative detection of SARS-CoV-2 from human nasopharyngeal swabs, eluted directly into deionised water without an additional RNA extraction process (extraction-free). Increase of global SARS-CoV-2 testing worldwide has posed new challenges to laboratories in nearly all … [Read more...] about Eurofins Launches New ultra-fast Extraction-free RT-PCR Method and Upgrades its RT-PCR Assay for Use with Pharynx Gargle and Saliva Sample Matrices
Eurofins Launches Quantitative Antibody Test to Measure Immune Response to COVID-19 and Vaccines
Eurofins launches a new CE marked serological assay for the identification and quantification of antibodies to SARS-CoV-2. This ELISA kit can support vaccination campaigns by confirming the success of a vaccination and monitoring the antibody levels over time. Vaccination against COVID-19 is a critical element in the fight against the pandemic. The spike protein covers the surface of the … [Read more...] about Eurofins Launches Quantitative Antibody Test to Measure Immune Response to COVID-19 and Vaccines
100,000 Fast PCR Tests to Detect Covid-19 Donated to Hospitals Worldwide
Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world Eurofins is making new assays for the identification of B.1.1.7 (UK) and B.1.351 (South Africa)/B.1.1.248 (Brazil) variants with a one hour run time available for free to public health institutions who do not have capabilities to … [Read more...] about 100,000 Fast PCR Tests to Detect Covid-19 Donated to Hospitals Worldwide
Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world
Eurofins is making new assays for the identification of B.1.1.7 (UK) and B.1.351 (South Africa)/B.1.1.248 (Brazil) variants with a one hour run time available for free to public health institutions who do not have capabilities to rapidly identify the presence of these variants. SARS-CoV-2 belongs to a group of RNA viruses that exhibit spontaneous mutations. Some alarming variants have recently … [Read more...] about Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world
Massive capacity detecting and monitoring new variants of SARS-CoV-2
Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2 The increasing diversity of SARS-CoV-2 variants and the potential higher infectivity of some new viral strains, underline the need to identify, trace and track mutations across the complete viral genome. Currently, strains of concern include the B.1.1.7 variant, first identified in the United … [Read more...] about Massive capacity detecting and monitoring new variants of SARS-CoV-2
Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2
The increasing diversity of SARS-CoV-2 variants and the potential higher infectivity of some new viral strains, underline the need to identify, trace and track mutations across the complete viral genome. Currently, strains of concern include the B.1.1.7 variant, first identified in the United Kingdom, and the B.1.351 variant, first identified in South Africa. Eurofins is pleased to announce the … [Read more...] about Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2
Cost-effective SARS-CoV-2 full-length viral genome sequencing services
Eurofins Genomics launches cost-effective SARS-CoV-2 full-length viral genome sequencing services essential in the identification of viral mutations … [Read more...] about Cost-effective SARS-CoV-2 full-length viral genome sequencing services
Eurofins Genomics launches cost-effective SARS-CoV-2 full-length viral genome sequencing services essential in the identification of viral mutations
Eurofins Genomics launches an optimized, cost-effective, SARS-CoV-2, next-generation sequencing service providing full length viral genome sequences. The best-in-class ARTIC NGS Oligo mix synthesized by Eurofins Genomics’ Synthesis branch will also be commercially available shortly. The new NGS service and ARTIC NGS oligo kit are Eurofins’ latest additions to a comprehensive product portfolio to … [Read more...] about Eurofins Genomics launches cost-effective SARS-CoV-2 full-length viral genome sequencing services essential in the identification of viral mutations
Eurofins launches COVID-19 PCR tests with at-home self-sampling options
Eurofins launches COVID-19 PCR tests with at-home self-sampling options in Europe and donates sequencing capacity to identify VUI-2020-12/01 strain reported to spread faster in the UK. … [Read more...] about Eurofins launches COVID-19 PCR tests with at-home self-sampling options